Barriers to obtaining gene expression profiling tests heightened their perceived importance among
patients with early breast cancer who were deciding whether to have chemotherapy, a new study says.
The researchers analysed the radiotherapy treatment plans of 1145 patients
with early breast cancer who had previously had breast - conserving surgery.
SATURDAY, May 31 (HealthDay News)-- A drug used to treat osteoporosis lowered the risk of breast cancer recurrence in premenopausal
women with early breast cancer.
January 14, 2000 Protein predicts prognosis for breast cancer patients Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which
patients with early breast cancer will need chemotherapy following surgery.
«Intensity modulated radiotherapy reduces side effects in patients
with early breast cancer.»
Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients
with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO).
Low levels of a protein that helps link cells together appears to be the single most effective factor for predicting which patients
with early breast cancer will need chemotherapy following surgery, report researchers from the University of Chicago Medical Center in the January 15, 2000 issue of Cancer Research.
Summary: Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which patients
with early breast cancer will need chemotherapy following surgery.